NCT06218303 2026-03-12
Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ
University of Pittsburgh
Phase 1 Recruiting
Clinical Trials
6 trialsNCT04144023 2026-03-05
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
Mayo Clinic
Phase 1 Recruiting
NCT07408856 2026-02-13
CAN1012 in OED, DCIS, and LCIS.
Providence Health & Services
Phase 1 Not yet recruiting
NCT05340673 2026-01-28
Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer
City of Hope Medical Center
Phase 1 Active not recruiting
NCT07178665 2025-11-14
Pilot Trial of Preop Partial Radiation in Breast Cancer Patients
Rutgers, The State University of New Jersey
Phase 1 Suspended
NCT03317405 2025-08-28
Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery
National Cancer Institute (NCI)
Phase 1 Active not recruiting